Journal of General Internal Medicine

, Volume 23, Issue 1, pp 11–18

Care in the Months before Death and Hospice Enrollment Among Older Women with Advanced Breast Cancer

  • Nancy L. Keating
  • Mary Beth Landrum
  • Edward Guadagnoli
  • Eric P. Winer
  • John Z. Ayanian
Original Article

Abstract

Background

Variations in hospice use are not well understood.

Objective

Assess whether care before death, including the types of physicians seen, number of outpatient visits, and hospitalizations, was associated with hospice use and the timing of enrollment.

Design/setting

Observational study of a population-based sample of advanced breast cancer patients included in the Surveillance, Epidemiology, and End Results—Medicare database.

Patients

There were 4,455 women aged ≥65 diagnosed with stage III/IV breast cancer during 1992–1999 who died before the end of 2001.

Measurements

Hospice use and, among enrollees, enrollment within 2 weeks of death. Independent variables of interest included hospitalizations, outpatient visits, and physicians seen before death.

Results

Adjusted hospice use rates were higher for hospitalized patients (45% if hospitalized for 1–7 days, 46% if 8–20 days, 35% if ≥21 days) than those not hospitalized (31%, P < 0.001). Adjusted rates were also higher among patients seeing a cancer specialist and primary care provider (PCP; 41%) and those seeing a cancer specialist and no PCP (38%) than among those seeing a PCP and no cancer specialist (30%) or neither type of physician (22%; P < 0.001). Hospice use also increased with increasing frequency of outpatient visits (P < 0.001). Hospitalizations, physicians seen, and visits were not associated with referral within 2 weeks of death (all P ≥ 0.10).

Discussion

Care before death is associated with hospice use among older women with advanced breast cancer. Additional research is needed to understand better how differences in patient characteristics and disease status influence cancer care before death and the role of various types of physicians in hospice referrals.

KEY WORDS

end-of-life care breast cancer outpatient care 

References

  1. 1.
    Institute of Medicine, ed. Improving Palliative Care for Cancer. Washington, D.C.: National Academy Press; 2001.Google Scholar
  2. 2.
    Greer DS, Mor V. An overview of National Hospice Study findings. J Chronic Dis. 1986;39(1):5–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Greer DS, Mor V, Morris JN, Sherwood S, Kidder D, Birnbaum H. An alternative in terminal care: results of the National Hospice Study. J Chronic Dis. 1986;39(1):9–26.PubMedCrossRefGoogle Scholar
  4. 4.
    Wallston KA, Burger C, Smith RA, Baugher RJ. Comparing the quality of death for hospice and non-hospice cancer patients. Med Care. 1988;26(2):177–82.PubMedCrossRefGoogle Scholar
  5. 5.
    General Accounting Office. Medicare: More beneficiaries use hospice; many factors contribute to shorter periods of use. 2000 September 18, 2000.Google Scholar
  6. 6.
    Medicare Payment Advisory Commission (MedPAC). Report to the Congress: Medicare Beneficiaries’ Access to Hospice. 2002 May.Google Scholar
  7. 7.
    Medicare Payment Advisory Commission (MedPAC). Medicare’s hospice benefit: Recent trends and consideration of payment system refinements. 2006 Jun.Google Scholar
  8. 8.
    Berry ZS, Lynn J. Hospice medicine. JAMA. 1993;270(2):221–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Virnig BA, Kind S, McBean M, Fisher E. Geographic variation in hospice use prior to death. J Am Geriatr Soc. 2000;48(9):1117–25.PubMedGoogle Scholar
  10. 10.
    Lackan NA, Ostir GV, Freeman JL, Mahnken JD, Goodwin JS. Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer. Med Care. 2004;42(2):116–22.PubMedCrossRefGoogle Scholar
  11. 11.
    Virnig BA, Persily NA, Morgan RO, DeVito CA. Do Medicare HMOs and Medicare FFS differ in their use of the Medicare hospice benefit? Hosp J. 1999;14(1):1–12.PubMedGoogle Scholar
  12. 12.
    Talamantes MA, Lawler WR, Espino DV. Hispanic American elders: caregiving norms surrounding dying and the use of hospice services. Hosp J. 1995;10(2):35–49.PubMedCrossRefGoogle Scholar
  13. 13.
    Ngo-Metzger Q, McCarthy EP, Burns RB, Davis RB, Li FP, Phillips RS. Older Asian Americans and Pacific Islanders dying of cancer use hospice less frequently than older white patients. Am J Med. 2003;115(1):47–53.PubMedCrossRefGoogle Scholar
  14. 14.
    Greiner KA, Perera S, Ahluwalia JS. Hospice usage by minorities in the last year of life: results from the National Mortality Followback Survey. J Am Geriatr Soc. 2003;51(7):970–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Lackan NA, Freeman JL, Goodwin JS. Hospice use by older women dying with breast cancer between 1991 and 1996. J Palliat Care. 2003;19(1):49–53.PubMedGoogle Scholar
  16. 16.
    Lackan NA, Ostir GV, Kuo YF, Freeman JL. The association of marital status and hospice use in the USA. Palliat Med. 2005;19(2):160–2.PubMedCrossRefGoogle Scholar
  17. 17.
    McCarthy EP, Burns RB, Ngo-Metzger Q, Davis RB, Phillips RS. Hospice use among Medicare managed care and fee-for-service patients dying with cancer. JAMA. 2003;289(17):2238–45.PubMedCrossRefGoogle Scholar
  18. 18.
    Virnig BA, Fisher ES, McBean AM, Kind S. Hospice use in Medicare managed care and fee-for-service systems. Am J Manag Care. 2001;7(8):777–86.PubMedGoogle Scholar
  19. 19.
    Iwashyna TJ, Chang VW, Zhang JX, Christakis NA. The lack of effect of market structure on hospice use. Health Serv Res. 2002;37(6):1531–51.PubMedCrossRefGoogle Scholar
  20. 20.
    Wennberg JE, Fisher ES, Stukel TA, Skinner JS, Sharp SM, Bronner KK. Use of hospitals, physician visits, and hospice care during last six months of life among cohorts loyal to highly respected hospitals in the United States. BMJ. 2004;328(7440):607.PubMedCrossRefGoogle Scholar
  21. 21.
    Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004;22(2):315–21.PubMedCrossRefGoogle Scholar
  22. 22.
    Keating NL, Herrinton L, Zaslavsky AM, Liu L, Ayanian JZ. Variations in hospice use among cancer patients. J Natl Cancer Inst. 2006;98:1053–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Navari RM, Stocking CB, Siegler M. Preferences of patients with advanced cancer for hospice care. JAMA. 2000;284(19):2449.PubMedCrossRefGoogle Scholar
  24. 24.
    Bradley EH, Cramer LD, Bogardus ST, Jr., Kasl SV, Johnson-Hurzeler R, Horwitz SM. Physicians’ ratings of their knowledge, attitudes, and end-of-life-care practices. Acad Med. 2002;77(4):305–11.PubMedCrossRefGoogle Scholar
  25. 25.
    Institute of Medicine, ed. Approaching death-improving care at the end of life. Washington, DC: National Academy Press; 1997.Google Scholar
  26. 26.
    Levinsky NG, Yu W, Ash A, et al. Influence of age on Medicare expenditures and medical care in the last year of life. JAMA. 2001;286(11):1349–55.PubMedCrossRefGoogle Scholar
  27. 27.
    Christakis NA, Escarce JJ. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med. 1996;335(3):172–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Christakis NA, Lamont EB. Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ. 2000;320(7233):469–72.PubMedCrossRefGoogle Scholar
  29. 29.
    Stillman MJ, Syrjala KL. Differences in physician access patterns to hospice care. J Pain Symptom Manage. 1999;17(3):157–63.PubMedCrossRefGoogle Scholar
  30. 30.
    Lamont EB, Christakis NA. Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer. 2002;94(10):2733–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Christakis NA, Iwashyna TJ. Impact of individual and market factors on the timing of initiation of hospice terminal care. Med Care. 2000;38(5):528–41.PubMedCrossRefGoogle Scholar
  32. 32.
    Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31(8):732–48.PubMedCrossRefGoogle Scholar
  33. 33.
    Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer. 2000;88(10):2398–424.PubMedCrossRefGoogle Scholar
  34. 34.
    Baldwin LM, Adamache W, Klabunde C, Kenward K, Dalhman C, Warren JL. Linking physician characteristics and Medicare claims data: issues in data availability, quality, and measurement. Med Care. 2002;40(8, Supplement):IV-82–IV-95.Google Scholar
  35. 35.
    American Joint Committee on Cancer. AJCC cancer staging manual, 5th edition New York, NY: Springer; 1997.Google Scholar
  36. 36.
    Ellis RP, Pope GC, Iezzoni LI, et al. Diagnosis-based risk adjustment for Medicare capitation payments. Health Care Financing Rev. 1996;17(3):101–28.Google Scholar
  37. 37.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.PubMedCrossRefGoogle Scholar
  38. 38.
    Ash AS, Posner MA, Speckman J, Franco S, Yacht AC, Bramwell L. Using claims data to examine mortality trends following hospitalization for heart attack in Medicare. Health Serv Res. 2003;38(5):1253–62.PubMedCrossRefGoogle Scholar
  39. 39.
    Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G. In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care. 2006;44(8):745–53.PubMedCrossRefGoogle Scholar
  40. 40.
    Little RJ. Direct standardization: a tool for teaching linear models for unbalanced data. Am Statistician. 1982;36:38–43.CrossRefGoogle Scholar
  41. 41.
    Leape LL, Hilborne LH, Bell R, Kamberg C, Brook RH. Underuse of cardiac procedures: do women, ethnic minorities, and the uninsured fail to receive needed revascularization? Ann Intern Med. 1999;130:183–92.PubMedGoogle Scholar
  42. 42.
    Bradley EH, Fried TR, Kasl SV, Cicchetti DV, Johnson-Hurzeler R, Horwitz SM. Referral of terminally ill patients for hospice: frequency and correlates. J Palliat Care. 2000;16(4):20–6.PubMedGoogle Scholar
  43. 43.
    Iwashyna TJ, Christakis NA. Attitude and self-reported practice regarding hospice referral in a national sample of internists. J Palliat Med. 1998;1:241–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 Suppl):IV-3–IV-18.Google Scholar
  45. 45.
    Locher JL, Kilgore ML, Morrisey MA, Ritchie CS. Patterns and predictors of home health and hospice use by older adults with cancer. J Am Geriatr Soc. 2006;54(8):1206–11.PubMedCrossRefGoogle Scholar
  46. 46.
    Bach PB, Schrag D, Begg CB. Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA. 2004;292(22):2765–70.PubMedCrossRefGoogle Scholar
  47. 47.
    Earle CC, Ayanian JZ. Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol. 2006;24:838–40.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2007

Authors and Affiliations

  • Nancy L. Keating
    • 1
    • 2
  • Mary Beth Landrum
    • 2
  • Edward Guadagnoli
    • 2
  • Eric P. Winer
    • 3
  • John Z. Ayanian
    • 1
    • 2
  1. 1.Division of General Internal Medicine, Department of MedicineBrigham and Women’s HospitalBostonUSA
  2. 2.Department of Health Care PolicyHarvard Medical SchoolBostonUSA
  3. 3.Department of Adult OncologyDana-Farber Cancer InstituteBostonUSA

Personalised recommendations